Differential P21 Expression and Point Mutations of ras Gene Family in Human Carcinoma Tissues

  • Yuji Mizukami
  • Akitaka Nonomura
  • Fujitsugu Matsubara
  • Masakuni Noguchi
  • Shinobu Nakamura
Part of the NATO ASI Series book series (NSSA, volume 220)


The mammalian ras oncogene family consisits of three well-characterized members, N-ras, K-ras and H-ras. The amino acid sequence of the 21-Kd proteins encoded by these three ras members is known to be nearly identical except in two short variable regions1,2. Concerning the expression of ras p21 in human tissues, many immunohistochemical studies have been reported using monoclonal antibodies against ras protein3–5. However, these antibodies were unable to distinguish N-ras, K-ras and H-ras p21, respectively. Recently, monoclonal antibodies against each of N-ras, K-ras and H-ras p21 have been developed and made available commercially. In the present study, we examined the differential p21 expression of the three members of ras family in human carcinoma tissues of various organs by the immunohistochemical method.


Breast Carcinoma Thyroid Carcinoma Carcinoma Histology Human Medullary Thyroid Carcinoma Cell Harvey Murine Sarcoma Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    K. Shimizu, D. Birnbaum, M.A. Ruley, O. Fasano, Y. Suard, L. Edlund, E. Taparowsky, M. Goldfarb, and M. Wigler. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature 304:497(1983).PubMedCrossRefGoogle Scholar
  2. 2.
    E. Taparowsky, K Shimizu, M. Goldfarb, and M. Wigler. Structure and activation of the human N-ras gene. Cell 34:581 (1983).PubMedCrossRefGoogle Scholar
  3. 3.
    Y. Mizukami, A. Nonomura, T. Hashimoto, S. Terahata, F. Matsubara, T. Michigishi, and M. Noguchi. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign and malignant human thyroid tissues. Cancer 61:873 (1988).PubMedCrossRefGoogle Scholar
  4. 4.
    M.V. Viola, F. Fromowitz, M.S. Oraves, S.D. Deb, G. Finkel, J. Lundy, P. Hand, A. Thor, and J. Schlom. Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314:133 (1986).PubMedCrossRefGoogle Scholar
  5. 5.
    A.K. Ghosh, M. Moore, and M. Harris. Immunohistochemical detection of ras oncogene p21 product in benign and mammary tissues in man. J Clin Pathol 39:428 (1986).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Barbacid. Ras genes. Annu Rev Biochem 56:779 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    J.L. Bos. Ras oncogenes in human cancer: a review. Cancer Res 49:4682 (1989).PubMedGoogle Scholar
  8. 8.
    M. Tada, O. Yokosuka, M. Ornata, M. Ohta, and K. Isono. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 66:930 (1990).PubMedCrossRefGoogle Scholar
  9. 9.
    N.R. Lemoine, E.S. Mayall, F.S. Wyllie, D. Williams, M. Goyns, B. Stringer, and D.Y. Thomas. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159 (1989).PubMedGoogle Scholar
  10. 10.
    J.L. Bos, E.R. Fearon, S.R. Hamilton, M.V. Vries, J.H. van Boom, A.J. van der Eb, and B. Vogelstein. Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293 (1987).PubMedCrossRefGoogle Scholar
  11. 11.
    R.J.C. Slebos, R.E. Kibbelaar, O. Dalesio, A. Kooistra, J. Stam, C.J.L.M. Meijer, S.S. Wagenaar, R.G.J.R.A. Van der schueren, N.V. Zandwijk, W.J. Mooi, J.L. Bos, and S. Rodenhuis. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561 (1990).PubMedCrossRefGoogle Scholar
  12. 12.
    T. Kobayashi, H. Tsuda, M. Noguchi, S. Hirohashi, Y. Shimosato, T. Goya, and Y. Hayata. Association of point mutation in c-K-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 66:289 (1990).PubMedCrossRefGoogle Scholar
  13. 13.
    R.K. Saiki, D.H. Gelfand, S. Stoffel, S.J. Schrf, R. Higuchi, G.T. Horn, K.B. Mullis, H.A. Erlich. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    E.G. Chang, M. E. Furth, E.M. Scolnick, and D.R. Lowy. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297:479 (1982).PubMedCrossRefGoogle Scholar
  15. 15.
    D. Defeo, M.A. Gonda, H.A. Young, E.H. Chang, D.R. Lowy, E.M. Scolnick, and R.W. Ellis. Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci USA 78:3328 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    M.E. Furth, T.H. Aldrich, and C. Cordon-Cardo. Expression of ras protooncogene proteins in normal human tissues. Oncogene 1:47 (1987).PubMedGoogle Scholar
  17. 17.
    J. Leon, I. Guerrero, and A. Pellicer. Differential expression of the ras gene family in mice. Mol Cell Biol 7:1535 (1987).PubMedGoogle Scholar
  18. 18.
    T. Nakagawa, M. Mabry, A. De Bustros, J.N. Ihle, B.D. Nelkin, S.B. Baylin. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci USA 84:5923 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Yuji Mizukami
    • 1
  • Akitaka Nonomura
    • 1
  • Fujitsugu Matsubara
    • 1
  • Masakuni Noguchi
    • 2
  • Shinobu Nakamura
    • 3
  1. 1.Pathology SectionKanazawa University HospitalKanazawa, 920Japan
  2. 2.Surgery MedicineKanazawa University HospitalKanazawa, 920Japan
  3. 3.Internal MedicineKanazawa University HospitalKanazawa, 920Japan

Personalised recommendations